(Q44380016)

2 December 2017

title

A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma (English)

1 reference

2 December 2017

6

1 reference

2 December 2017

8

1 reference

2 December 2017

11

Francesco Montorsi

1 reference

2 December 2017

10

Alberto Briganti

1 reference

2 December 2017

12

Pierre I Karakiewicz

1 reference

2 December 2017

13

Maxine Sun

1 reference

2 December 2017

2

Giorgio Gandaglia

1 reference

2 December 2017

9

Florian Roghmann

1 reference

2 December 2017

3

Quoc-Dien Trinh

1 reference

2 December 2017

Marco Bianchi

1

1 reference

2 December 2017

Jens Hansen

series ordinal

4

1 reference

2 December 2017

Andreas Becker

series ordinal

5

1 reference

2 December 2017

Zhe Tian

series ordinal

7

1 reference

2 December 2017

publication date

17 September 2013

1 reference

2 December 2017

1 reference

2 December 2017

volume

32

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

46.e1-7

1 reference

EAU guidelines on renal cell carcinoma: the 2010 update

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

Guideline for management of the clinical T1 renal mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

Population-based external validation of a competing-risks nomogram for patients with localized renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

The natural history of observed enhancing renal masses: meta-analysis and review of the world literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

The natural history of small renal masses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

Validation of the 2009 TNM Version in a Large Multi-Institutional Cohort of Patients Treated for Renal Cell Carcinoma: Are Further Improvements Needed?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

Node-positive renal cell carcinoma in the absence of distant metastases: predictors of cancer-specific mortality in a population-based cohort.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

A stage-for-stage and grade-for-grade analysis of cancer-specific mortality rates in renal cell carcinoma according to age: a competing-risks regression analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

Chronic kidney disease after nephrectomy in patients with small renal masses: a retrospective observational analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

Lymphadenectomy improves survival of patients with renal cell carcinoma and nodal metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

Future of cancer incidence in the United States: burdens upon an aging, changing nation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

Percutaneous cryoablation of solitary sporadic renal cell carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

T2 clear cell renal cell carcinoma is a rare entity: a study of 120 clear cell renal cell carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.010

10.1016/J.UROLONC.2013.06.010

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference